Management of infections by the human polyomavirus JC: past, present and future (Q36233526)

12 August 2017

1 reference

title

Management of infections by the human polyomavirus JC: past, present and future (English)

1 reference

12 August 2017

human polyomavirus

1 reference

Jean Hou

1

1 reference

12 August 2017

Eugene Major

series ordinal

2

1 reference

12 August 2017

publication date

1 August 2005

1 reference

Expert Review of Anti-infective Therapy

12 August 2017

published in

1 reference

12 August 2017

volume

3

1 reference

12 August 2017

issue

4

1 reference

12 August 2017

page(s)

629-640

1 reference

Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.629

New human papovavirus (B.K.) isolated from urine after renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.629

Distribution and function of JCV agnoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.629

A classification scheme for human polyomavirus JCV variants based on the nucleotide sequence of the noncoding regulatory region

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.629

Progressive multifocal leuko-encephalopathy; a hitherto unrecognized complication of chronic lymphatic leukaemia and Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.629

Early pathological changes in progressive multifocal leukoencephalopathy: a report of two asymptomatic cases occurring prior to the AIDS epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.629

Polio vaccines, Simian Virus 40, and human cancer: the epidemiologic evidence for a causal association

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.629

Viruses and cancer: lessons from the human polyomavirus, JCV

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.629

Evidence against a role for SV40 infection in human mesotheliomas and high risk of false-positive PCR results owing to presence of SV40 sequences in common laboratory plasmids

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.629

The detection of Simian virus 40 in mesotheliomas from New Zealand and England using real time FRET probe PCR protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.629

Investigation of human brain tumors for the presence of polyomavirus genome sequences by two independent laboratories

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.629

Progressive multifocal leukoencephalopathy after stem cell transplantation, unsuccessfully treated with cidofovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.629

Polyomavirus infection in pediatric renal transplant recipients: evaluation using a quantitative real-time PCR technique

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.629

JC virus infection in allograft kidneys: analysis by polymerase chain reaction and immunohistochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.629

Association of JC virus with tubulointerstitial nephritis in a renal allograft recipient

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.629

Involvement of JC virus-infected mononuclear cells from the bone marrow and spleen in the pathogenesis of progressive multifocal leukoencephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.629

Traffic of JC virus from sites of initial infection to the brain: the path to progressive multifocal leukoencephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.629

Progressive multifocal leukoencephalopathy: a review of the pathology and pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.629

Lineage pathway of human brain progenitor cells identified by JC virus susceptability

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.629

JC virus DNA is present in the mucosa of the human colon and in colorectal cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.629

Detection of BK virus and JC virus DNA in urine samples from immunocompromised (HIV-infected) and immunocompetent (HIV-non-infected) patients using polymerase chain reaction and microplate hybridisation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.629

Documenting the epidemiologic patterns of polyomaviruses in human populations by studying their presence in urban sewage

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.629

Prognostic value of JC virus load in cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.629

Comparison of PCR-southern hybridization and quantitative real-time PCR for the detection of JC and BK viral nucleotide sequences in urine and cerebrospinal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.629

Relation of JC virus DNA in the cerebrospinal fluid to survival in acquired immunodeficiency syndrome patients with biopsy-proven progressive multifocal leukoencephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.629

JC virus DNA load in patients with and without progressive multifocal leukoencephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.629

The Evolving Face of Human Immunodeficiency Virus-Related Progressive Multifocal Leukoencephalopathy: Defining a Consensus Terminology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.629

Nucleoside analogues in the treatment of haematological malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.629

Progressive multifocal leukoencephalopathy and cytarabine. Remission with treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.629

Progressive multifocal leucoencephalopathy: remission with cytarabine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.629

Failure of cytarabine in progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. AIDS Clinical Trials Group 243 Team.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.629

Convection-enhanced intraparenchymal delivery (CEID) of cytosine arabinoside (AraC) for the treatment of HIV-related progressive multifocal leukoencephalopathy (PML).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.629

Treatment of non-AIDS progressive multifocal leukoencephalopathy with cytosine arabinoside

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.629

Progressive multifocal leukoencephalopathy treated with cidofovir in HIV-infected patients receiving highly active anti-retroviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.629

Failure of cidofovir therapy in progressive multifocal leukoencephalopathy unrelated to human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.629

Progressive multifocal leukoencephalopathy: cidofovir therapy in three patients with underlying hematological disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.629

Potent anti-retroviral therapy with or without cidofovir for AIDS-associated progressive multifocal leukoencephalopathy: extended follow-up of an observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.629

Cidofovir in AIDS-associated progressive multifocal leukoencephalopathy: a monocenter observational study with clinical and JC virus load monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.629

A pilot study of cidofovir for progressive multifocal leukoencephalopathy in AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.629

Remission of progressive multifocal leukoencephalopathy following splenectomy and antiretroviral therapy in a patient with HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.629

Remission of progressive multifocal leukoencephalopathy following highly active antiretroviral therapy in a patient with HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.629

The effect of potent antiretroviral therapy and JC virus load in cerebrospinal fluid on clinical outcome of patients with AIDS-associated progressive multifocal leukoencephalopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.629

Highly active antiretroviral therapy and progressive multifocal leukoencephalopathy: effects on cerebrospinal fluid markers of JC virus replication and immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.629

Treatment of AIDS-associated progressive multifocal leukoencephalopathy with highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.629

HAART improves prognosis in HIV-associated progressive multifocal leukoencephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.629

Clinical epidemiology and survival of progressive multifocal leukoencephalopathy in the era of highly active antiretroviral therapy: data from the Italian Registry Investigative Neuro AIDS (IRINA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.629

Progressive multifocal leukoencephalopathy in patients with AIDS receiving highly active antiretroviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.629

Highly active antiretroviral therapy significantly improves the prognosis of patients with HIV-associated progressive multifocal leukoencephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.629

Highly active antiretroviral therapy does not improve survival of patients with high JC virus load in the cerebrospinal fluid at progressive multifocal leukoencephalopathy diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.629

Inflammatory reactions in progressive multifocal leukoencephalopathy after highly active antiretroviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.629

Fatal immune restoration disease in human immunodeficiency virus type 1-infected patients with progressive multifocal leukoencephalopathy: impact of antiretroviral therapy-associated immune reconstitution

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.629

Fatal inflammatory AIDS-associated PML with high CD4 counts on HAART: a new clinical entity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.629

Immunorestitution disease involving the innate and adaptive response

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.629

The good and evil of HAART in HIV-related progressive multifocal leukoencephalopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.629

Low frequency of cytotoxic T lymphocytes against the novel HLA-A*0201-restricted JC virus epitope VP1(p36) in patients with proven or possible progressive multifocal leukoencephalopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.629

Critical role of JC virus-specific CD4 T-cell responses in preventing progressive multifocal leukoencephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.629

Topoisomerase I inhibition with topotecan: pharmacologic and clinical issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.629

Inhibition of human neurotropic virus (JCV) DNA replication in glial cells by camptothecin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.629

Efficacy of camptothecin in progressive multifocal leucoencephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.629

Progressive multifocal leucoencephalopathy with magnetic resonance imaging verification and therapeutic trials with interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.629

Survival prolongation in HIV-associated progressive multifocal leukoencephalopathy treated with alpha-interferon: an observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.629

Early events in the life cycle of JC virus as potential therapeutic targets for the treatment of progressive multifocal leukoencephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.629

A combination of low-dose chlorpromazine and neutralizing antibodies inhibits the spread of JC virus (JCV) in a tissue culture model: implications for prophylactic and therapeutic treatment of progressive multifocal leukencephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.629

The human polyomavirus, JCV, uses serotonin receptors to infect cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.629

JC virus load in progressive multifocal leukoencephalopathy: analysis of the correlation between the viral burden in cerebrospinal fluid, patient survival, and the volume of neurological lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.629

A prospective study demonstrates an association between JC virus-specific cytotoxic T lymphocytes and the early control of progressive multifocal leukoencephalopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.629

The efficacy of nucleoside analogs against JC virus multiplication in a persistently infected human fetal brain cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.629

The relative contributions of HAART and alpha-interferon for therapy of progressive multifocal leukoencephalopathy in AIDS

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.4.629

21 January 2018

Identifiers

DOI

10.1586/14787210.3.4.629

1 reference

release_ahpatuqhdjhalem3uctknhzwmq

12 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ahpatuqhdjhalem3uctknhzwmq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference